The fairness paradox in public regulatory summaries of FDA-authorized artificial intelligence-enabled medical devices
The U. S. Food and Drug Administration has published several types of public regulatory summaries of artificial intelligence-enabled medical devices, including 510(k) summaries, De Novo decision summaries, and premarket approval summaries of safety and effectiveness data. These documents are among the few regulatory te...